Clinical Nurse Specialist Risk Assessment & Management 2 — Questions and Answers
Question 1: A CNS is reviewing a patient's medication reconciliation list on admission. Which action best reduces polypharmacy-related risk in elderly patients?
- Discontinue all non-essential medications immediately
- Use the Beers Criteria to identify potentially inappropriate medications (Correct answer)
- Limit the patient to a maximum of five medications
- Defer medication review to the attending physician only
Correct answer: Use the Beers Criteria to identify potentially inappropriate medications
The Beers Criteria provides an evidence-based list of medications that are potentially inappropriate for older adults and guides risk reduction in polypharmacy.
Question 2: Which validated tool is most appropriate for a CNS to use when assessing a hospitalized patient's risk for venous thromboembolism (VTE)?
- Braden Scale
- Caprini Score (Correct answer)
- AUDIT-C
- PHQ-9
Correct answer: Caprini Score
The Caprini Score is a validated risk assessment model widely used to stratify VTE risk in hospitalized patients and guide prophylaxis decisions.
Question 3: A CNS notices that post-operative infection rates on a surgical unit have increased over three months. What is the FIRST priority in addressing this patient safety risk?
- Implement mandatory antibiotic prophylaxis for all surgical patients
- Conduct a root cause analysis to identify contributing factors (Correct answer)
- Report the trend to The Joint Commission immediately
- Replace all current wound care protocols
Correct answer: Conduct a root cause analysis to identify contributing factors
A root cause analysis is the first step to systematically identify the underlying causes of an adverse trend before implementing solutions.
Question 4: When using failure mode and effects analysis (FMEA) in risk management, the CNS is primarily focused on:
- Investigating errors that have already caused patient harm
- Prospectively identifying potential failure points before harm occurs (Correct answer)
- Calculating the financial cost of adverse events
- Assigning accountability for past medication errors
Correct answer: Prospectively identifying potential failure points before harm occurs
FMEA is a proactive risk management technique that identifies potential failure modes and their effects before an adverse event occurs.
Question 5: A patient with a history of substance use disorder is prescribed opioids for post-operative pain. Which risk assessment tool should the CNS use to evaluate opioid misuse risk?
- Glasgow Coma Scale
- Opioid Risk Tool (ORT) (Correct answer)
- CAGE questionnaire
- CIWA-Ar protocol
Correct answer: Opioid Risk Tool (ORT)
The Opioid Risk Tool (ORT) is validated for predicting aberrant drug-related behaviors in patients prescribed opioids for chronic pain.
Question 6: A CNS is implementing a handoff communication protocol to reduce information loss between shifts. Which standardized framework is MOST appropriate?
- SBAR (Situation, Background, Assessment, Recommendation) (Correct answer)
- PDSA (Plan, Do, Study, Act)
- SOAP (Subjective, Objective, Assessment, Plan)
- RACE (Rescue, Alarm, Confine, Evacuate)
Correct answer: SBAR (Situation, Background, Assessment, Recommendation)
SBAR provides a structured framework for healthcare communication during handoffs, reducing information gaps and improving patient safety.
Question 7: Which factor most significantly increases a patient's risk for hospital-acquired pressure injuries according to current CNS practice guidelines?
- Age over 40 years
- Impaired sensory perception combined with limited mobility (Correct answer)
- BMI greater than 25
- History of diabetes mellitus without neuropathy
Correct answer: Impaired sensory perception combined with limited mobility
The combination of impaired sensory perception and limited mobility prevents patients from detecting and relieving pressure, dramatically increasing pressure injury risk.
A CNS is reviewing a patient's medication reconciliation list on admission.
Which action best reduces polypharmacy-related risk in elderly patients?